| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/08/2004 | US20040132691 Applying a protective coatings on stents, catheters, pacemakers, breast implants, contact lenses and shunts, from inflammatory cells and platelets to a medical device; cell culturing |
| 07/08/2004 | US20040132690 Gel based on chitosan and lactic acid; acidity; dosage form suppository or vaginal tablet; prevention and treatment of vaginal Infections, restoring the physiological lactobacilli flora |
| 07/08/2004 | US20040132689 Aqueous preparation containing a shark-derived chondroitin iron sulfate colloid |
| 07/08/2004 | US20040132688 Antithrombotic factor comprising glycolipid; glycosylceramide is glucose linked covalently to ceramide; diagnosis of determine individuals for thrombosis; drug screening; drug delivery; anti-inflammatory factor, nutritional supplements |
| 07/08/2004 | US20040132686 C2,5'- disubstituted and N6, c2,5'- trisubstituted adenosine derivatives and their different uses |
| 07/08/2004 | US20040132685 Immunostimulatory nucleic acid |
| 07/08/2004 | US20040132681 Antisense modulation of beta-site APP-cleaving enzyme 2 expression |
| 07/08/2004 | US20040132676 Polynucleotide formulation for enhanced intracellular transfer |
| 07/08/2004 | US20040132673 Clathrate of azithromycin hydrate with 1,2-propyleneglycol, method for the manufacture thereof and pharmaceutical composition comprising same |
| 07/08/2004 | US20040132672 Method for inhibiting cancer cells |
| 07/08/2004 | US20040132671 Quercetin derivatives and their medical usages |
| 07/08/2004 | US20040132670 Method of production of an isomaltulose-containing enteral nutrient |
| 07/08/2004 | US20040132668 Crystalline 1-methylcarbapenem derivatives |
| 07/08/2004 | US20040132666 Administration of free radical scavengers to prevent or treat ischemia-reperfusion injuries |
| 07/08/2004 | US20040132660 PRO256 polypeptide; wound healing and anticarcinogenic agents; cardiovascular disorders, atherosclerosis, and cardiac hypertrophy treatment |
| 07/08/2004 | US20040132655 New combination |
| 07/08/2004 | US20040132644 Composition and method for treating diabetes |
| 07/08/2004 | US20040132643 Histone deacelylase inhibitors in diagnosis and treatment of thyroid neoplasms |
| 07/08/2004 | US20040132638 Administering modified hemoglobins comprising nitrosylhemoglobin, nitrosyl-heme, metal substituted heme iron, or nitrosyl-porphyrin; vasodilation; anticoagulants; synthetic blood |
| 07/08/2004 | US20040132636 Pharmaceutical uses for alpha2delta ligands |
| 07/08/2004 | US20040132633 Using direct search algorithm moving away from a vertex which represents a least desirable dose combination; data processing, mathematics, computers |
| 07/08/2004 | US20040132618 Therapeutic amides |
| 07/08/2004 | US20040132181 Trans-splicing mediated photodynamic therapy |
| 07/08/2004 | US20040132179 Treatment of t cell disorders |
| 07/08/2004 | US20040132161 Methods and compositions for increasing CD4lymphocyte immune responsiveness |
| 07/08/2004 | US20040132139 Comprises nucleotide sequences coding protein with antiproliferative and viricidal activity for use in treatment and prevention of cancer, nervous system, bone and autoimmune disorders |
| 07/08/2004 | US20040132115 Method for screening compounds for alpha1B adrenergic receptor antagonist and analgesic activity |
| 07/08/2004 | US20040132053 Sphingosine kinase enzyme |
| 07/08/2004 | US20040132038 Membrane protein for use as diagnostic tool in the detection and prevention of cell proliferative, cardiovascular, skin, nervous system, respiratory and metabolic disorders |
| 07/08/2004 | US20040132012 Nucleotide sequences consisiting of DNA viral open reading frames which code proteins which can be used to prepare genetic vaccines which prevent viral diseases |
| 07/08/2004 | US20040131733 solubilisation of lycopene in this supercritical fluid and to separate the lycopene concentrate by depressurisation carried out at pressures below 10 MPa to produce an oleoresin |
| 07/08/2004 | US20040131712 Anti diarrhoea compositions |
| 07/08/2004 | US20040131710 Methods for treating skin conditions |
| 07/08/2004 | US20040131708 containing 2-(4-hydroxyphenyl)ethyl- beta -d-glucopyranoside or 3-[6-o-( alpha -l-arabinopyranosyl)- beta -d-glucopyranosyl]-oxy-1-phenylpropene |
| 07/08/2004 | US20040131707 an aqueous Soma, comprising apple cider vinegar, quinine, blackstrap molasses, sulfur, and whole milk; suited for treating lymphoid malignancies |
| 07/08/2004 | US20040131705 contains at least one additional anti-inflammatory agent such as indomethacin or another nonsteroidal anti-inflammatory drug; for oral, topical or injection administration; humate is prehistoric |
| 07/08/2004 | US20040131703 Antiinflammatory agents; respiratory system disorders |
| 07/08/2004 | US20040131701 Method to treat infectious diseases and/or to enhance antimicrobial efficacy of drugs |
| 07/08/2004 | US20040131700 Prevent plaque forming in tissue |
| 07/08/2004 | US20040131698 Methods of treating conditions using metal-containing materials |
| 07/08/2004 | US20040131694 Mixture of polysaccharides, thymus and prostate extract, carbohydrates in solvent; freezing, storage |
| 07/08/2004 | US20040131692 Nanoparticles made of protein with coupled apolipoprotein e for penetration of the blood-brain barrier and methods for the production thereof |
| 07/08/2004 | US20040131689 Method to obtain microparticles containing a h+, k+ -atp-ase inhibitor |
| 07/08/2004 | US20040131686 Composition and method for treatment of bacterial vaginal infections |
| 07/08/2004 | US20040131685 Sustained release mixture; respiratory system disorders; antiallergens |
| 07/08/2004 | US20040131684 Omeprazole formulation |
| 07/08/2004 | US20040131683 Compositions for conjugated estrogens and associated methods |
| 07/08/2004 | US20040131681 Antibiotic microspheres for treatment of infections and osteomyelitis |
| 07/08/2004 | US20040131680 Side effect reduction |
| 07/08/2004 | US20040131679 Process for producing an oral sustained-release preparation of fasudil hydrochloride |
| 07/08/2004 | US20040131676 Dosage forms containing a PPI, NSAID, and buffer |
| 07/08/2004 | US20040131674 Gastric acid secretion inhibiting composition |
| 07/08/2004 | US20040131671 Sustained release formulations containing acetaminophen and tramadol |
| 07/08/2004 | US20040131670 Pellicle-resistant gelatin capsule |
| 07/08/2004 | US20040131667 Liposomal analgesic formulation and use |
| 07/08/2004 | US20040131666 Liposome encapsulating active materials |
| 07/08/2004 | US20040131665 Topical anesthetic formulation |
| 07/08/2004 | US20040131664 Topical stabilized prostaglandin E compound dosage forms |
| 07/08/2004 | US20040131663 Hydrophilic, flexible biopolymers; gel membrane permeable barrier; starch polymer; drug delivery |
| 07/08/2004 | US20040131657 Mixture of glucans and sterols |
| 07/08/2004 | US20040131656 Mixture of lycopene, lutein, ellagic acid, quercetin, hesperidin andepigallocatechin |
| 07/08/2004 | US20040131646 Gel delivery vehicles for anticellular proliferative agents |
| 07/08/2004 | US20040131644 Using phosphatides from poultry embryos |
| 07/08/2004 | US20040131631 Polyphosphazene immunostimulants |
| 07/08/2004 | US20040131629 Viricides: aids therapy |
| 07/08/2004 | US20040131619 Thymic atrophy |
| 07/08/2004 | US20040131618 Anticancer agents; diagnosis using alternation of gene expression |
| 07/08/2004 | US20040131615 Methods for treating pain by administering a nerve growth factor antagonist and an opioid analgesic and compositions containing the same |
| 07/08/2004 | US20040131611 Antitumor agents, anticancer agents; synergistic mixture |
| 07/08/2004 | US20040131608 Antibodies; suppression, therapy, prevention |
| 07/08/2004 | US20040131606 Product and process for liquefaction of mucus for sputum |
| 07/08/2004 | US20040131602 Methods for enhancing graft survival by modulating heme oxygenase activity |
| 07/08/2004 | US20040131596 Method and compositions for modifying target receptor function associated with neurological disorders |
| 07/08/2004 | US20040131590 Anticancer agents |
| 07/08/2004 | US20040131588 Formulation having mobilising activity |
| 07/08/2004 | US20040131574 Topical applying polyamines; enzyme inhibitors |
| 07/08/2004 | US20040131567 Mixture containing limonene; killing bacteria on skin, mucous membranes; psoriasis therapy |
| 07/08/2004 | US20040131564 Use of active ingredient combinations consisting of alpha-lipoic acid and dermatologically compatible substances that absorb light in the uv-a and or uv-b wavelength range(s) for producing cosmetic or dermatological preparations |
| 07/08/2004 | US20040131563 Therapy for pigmenting diseases; skin disorders |
| 07/08/2004 | US20040131555 Mixture of tobramycin in carrier; aerosols; respiratory system disorders |
| 07/08/2004 | US20040131553 Menopause therapy; hormone replacement therapy |
| 07/08/2004 | US20040131545 Anticholesterol agents |
| 07/08/2004 | US20040129112 Metal-containing materials |
| 07/08/2004 | DE202004006803U1 Kondom mit einer Beschichtung und Zusammensetzung Condom with a coating composition and |
| 07/08/2004 | DE19906979B4 Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit Use of deoxypeganine for the treatment of nicotine dependence |
| 07/08/2004 | DE19906978B4 Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit Pharmaceutical composition containing deoxypeganine for the treatment of drug addiction |
| 07/08/2004 | DE10261808A1 Verwendung von L-DOPA, seiner Derivate und diese Verbindungen enthaltender Arzneimittel zur Prophylaxe psychotischer Erkrankungen Use of L-DOPA, its derivatives and these compounds containing drug for the prophylaxis of psychotic disorders |
| 07/08/2004 | DE10260955A1 Verwendung von Steroidsulfatase-Inhibitoren zur Verminderung von Haarausfall Use of steroid sulfatase inhibitors to reduce hair loss |
| 07/08/2004 | DE10259646A1 Promoting therapy of parodontopathy, especially paradontitis, by topical application of mometasone furoate to teeth or interdental spaces |
| 07/08/2004 | DE10259619A1 Verwendung einer TRPM8 aktivierenden Substanz zur Tumorbehandlung Using a TRPM8-activating substance for tumor treatment |
| 07/08/2004 | DE10259200A1 Adhäsionshemmung von keratinophilen Pilzen Adhesion inhibition of fungi keratinophilic |
| 07/08/2004 | DE10259004A1 Use of new and known glucocorticoid receptor antagonists for treating hypogonadism, sexual dysfunction and infertility, with minimal effect on progesterone receptor |
| 07/08/2004 | DE10258008A1 Neue heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung New heterocyclic Fluorglycosidderivate, pharmaceutical compositions containing them and their use |
| 07/08/2004 | DE10257824A1 Zusammensetzung zur Schmerzbehandlung, insbesondere zur Behandlung von Gelenkschmerzen Composition for the treatment of pain, particularly for the treatment of joint pain |
| 07/08/2004 | DE10257478A1 Composition containing antioxidants and micronutrients, useful for treatment or prevention of paradontitis and associated disorders, also osteoporosis |
| 07/08/2004 | DE10257360A1 Gastro-intestinal verabreichbare Formulierung und deren Verwendung Gastro-intestinal administrable formulation and their use |
| 07/08/2004 | DE10237723A1 Verwendung von IKappaB-Kinase Inhibitoren in der Schmerztherapie Use of IkappaB kinase inhibitors in the treatment of pain |
| 07/08/2004 | DE10142662B4 Derivate von C2-substituierten Indan-1-ol-Systemen und ihre Verwendung als Arzneimittel Derivatives of C2-substituted indan-1-ol-systems and their use as medicaments |
| 07/08/2004 | CA2800237A1 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 07/08/2004 | CA2789415A1 Macrolides |